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Abstract
Background: Specific resistance loops appear in different shapes influenced by different resistive properties of the
airways, yet their descriptive ability is compressed to a single parameter - its slope. We aimed to develop new
parameters reflecting the various shapes of the loop and to explore their potential in the characterisation of
obstructive airways diseases.
Methods: Our study included 134 subjects: Healthy controls (N = 22), Asthma with non-obstructive lung function
(N = 22) and COPD of all disease stages (N = 90). Different shapes were described by geometrical and second-order
transfer function parameters.
Results: Our parameters demonstrated no difference between asthma and healthy controls groups, but were
significantly different (p < 0.0001) from the patients with COPD. Grouping mild COPD subjects by an open or not-open
shape of the resistance loop revealed significant differences of loop parameters and classical lung function parameters.
Multiple logistic regression indicated RV/TLC as the only predictor of loop opening with OR = 1.157, 95% CI
(1.064–1.267), p-value = 0.0006 and R2 = 0.35. Inducing airway narrowing in asthma gave equal shape measures
as in COPD non-openers, but with a decreased slope (p < 0.0001).
Conclusion: This study introduces new parameters calculated from the resistance loops which may correlate
with different phenotypes of obstructive airways diseases.
Keywords: Body-plethysmography, Airway resistance, Pulmonary function tests, Chronic obstructive pulmonary
disease, Asthma
Background
Obstructive lung diseases, predominantly asthma and
COPD, are a group of respiratory diseases characterized
by airflow limitation [1, 2]. The primary pathophysiologic
impairment in these diseases is an increase of airways re-
sistance that originates from mucosal and submucosal in-
flammation, bronchial constriction and airway collapse
during expiration. The rise in airways resistance requires
greater intrapleural pressure changes to provide sufficient
pressure gradients for the initiation and maintenance of
airflow. Airway resistance particularly increases during
expiration when positive intrathoracic pressures are fur-
ther compressing the intraluminal space of the airways [3].
From a diagnostic point of view spirometry is considered
as the gold standard to diagnose COPD and asthma, as well
as to assess the level of airway obstruction [4, 5]. Spirom-
etry requires forced maximal manoeuvres but cannot quan-
tify increased resistance of the airways at tidal breathing,
which may be characteristic and specific for the underlying
disease. Whole-body plethysmography, however, allows the
computation of airways resistance by measuring alveolar
pressure changes and corresponding airway flows during
tidal breathing in a closed body box [6]. More specifically,
plethysmography records the small changes in box pressure
by compression and decompression of thoracic gas which
correspond to small volume changes, also known as shift
volume. Simultaneously, it records airflow at the mouth
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generated by these subtle pressure changes. The relation-
ship between these two measurements is linearly expressed
as specific airways conductance (sGAW) or specific airways
resistance (sRAW) [7]. Hence, the diagnostic power of resist-
ance loops is reduced to one single parameter, the slope
of the linear relation, rather than to its differences in
shape which are affected by central or peripheral airway
obstruction, expiratory collapse or end-expiratory air-
way closing, and which may vary in function of the
breathing manoeuver and the thoracic gas volume (Fig. 1)
[6, 7]. As demonstrated in our previous work, the slope of
these loops is lacking discriminatory ability. It only mar-
ginally contributes to the diagnosis and differentiation of
COPD and asthma [8].
Different studies have identified some limitations of
the current parameterization of specific resistance loops,
mainly by its variability, the necessity for artefact correc-
tions and the clear evidence that the slope is significantly
determined by small changes in the breathing frequency
[9–11]. Similar observations were done with the forced
oscillation technique (FOT), demonstrating important
within and between-breath variation for which should be
corrected to identify real airway patency or obstruction
[12–15]. Other researchers have described methodologies
to optimize the slope estimation as a key parameter for
the calculation of airways resistance with plethysmography
[7, 16, 17]. However, to the best of our knowledge, no one
has explored the potential of other parameters that may
better reflect the curvilinear two-dimensional shape of
plethysmographic resistance loops.
We hypothesize that a more detailed mathematical
modelling of the tidal breathing loops may yield new
parameters which better represent the non-linear dy-
namics of specific resistance curves. With an empirical
model-based approach our first objective was to develop
geometrical parameters reflecting the shape of the loop.
Secondly, we designed second-order mathematical models
linking shift volumes to airflows during breathing. Finally,
we checked whether these newly developed parameters as-
sociated with other important lung function measures in
different clinical phenotypes of obstructive airways diseases.
Methods
Study subjects
For development of different mathematical models, lung
function data of 134 subjects were retrospectively collected
from a databank of the outpatient clinic of the University
Hospital of Leuven (Belgium) based on an established diag-
nosis of asthma (N = 22) or COPD (N = 90) and compared
with a healthy control group (N = 22). All enrolled subjects
were Caucasians between 19 and 84 years old who had per-
formed complete pulmonary function testing (including
post-bronchodilator spirometry, whole-body plethysmogra-
phy for lung volumes and airway resistance, and diffusing
capacity). All patients provided informed consent for the
use of lung function and clinical data and the protocol was
approved by the ethics committee of the University Hos-
pital of Leuven. Baseline characteristics of the subjects are
presented in the Table 1: i) Healthy group is defined as a
group of asymptomatic subjects without smoking history
with all lung function parameters falling in the normal ref-
erence range; ii) Asthma group: subjects with or without
smoking history, a previous clinical diagnosis of asthma
based on symptoms and therapy response, with a non-
obstructive lung function (post bronchodilator FEV1/FVC
ratio > 0.7) and positive reaction on inhaled methacholine
(FEV1 drop of at least 20% at maximal concentration of
8 mg/ml of methacholine) [18]; and iii) COPD group: sub-
jects with at least 10 pack-years of smoking history and
post-bronchodilator FEV1/FVC ratio below 0.7 [19]. In a
Fig. 1 Comparison of typical specific resistance loops: a Healthy subject, b Asthma subject, c COPD subject; Examples of asthma and COPD are
having almost identical sGAW (=0.60 [1/ kPa*sec]), yet they are visually completely different due to different resistive mechanisms
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subgroup of asthma subjects (N = 11), a methacholine chal-
lenge test was repeated with pre and post resistance and
lung volume measurements.
Pulmonary function tests
All pulmonary function tests were performed according
to the American Thoracic Society (ATS)/ European Re-
spiratory Society (ERS) criteria [20] using standardized
equipment (Masterscreen Jaeger, Carefusion, Germany).
Spirometry data are post-bronchodilator measures and
are expressed, along with pre-bronchodilator plethys-
mography measurements of airway resistance and lung
volume as percent predicted of normal reference values
[21, 22]. Diffusing capacity (DL,CO) was measured by the
single-breath carbon monoxide gas transfer method and
expressed as percent predicted of reference values [23].
Geometrical modelling
To geometrically explain the opening of the resistance
loops we developed a series of new parameters that may
capture what is visually apparent to the observer. From
each expiratory resistance loop, using the same elec-
tronic data and MATLAB software as in the transfer
function development, the following shape descriptive
parameters were derived:
1/ Area of the expiratory loop: it stands for total surface
covered by the expiratory phase of the breathing
manoeuver (Fig. 2, panel I.A). Area of loop (AOL) per
se is effort depended, as deeper breathing will cause
larger loop surfaces. Therefore, we normalized each
loop to a range [0, 1] for both flows and shift volumes.
2/ Roundness of the expiratory loop: In essence, this
parameter measures how closely the expiratory loop
approaches to a circle (Fig. 2, panel I.B). It appears
in an interval from 0 to 1, where 0 means complete
closure of the loop (flat line) while 1 means a
perfect circle. Smooth eclipses will have a low
roundness and an open loop is never expected to
reach a perfect circle. Roundness (Rnd) is defined
based on (Eq. 1):
Rnd ¼ 4π  ΑΟL
Perimeter2
ð1Þ
where AOL represents the complete area of the
normalised expiratory loop, and Perimeter is the
perimeter of the same loop.
3/ Median point of the expiratory loop: it is a two
dimensional measure, with the values coming from
both, X axis (median volume shift = point X) and Y
axis (median flow = point Y) in the expiratory phase
(Fig. 2, panel I.C). Ordinarily, both axes have a
negative value as somewhat longer expiration and
larger opening of the loop pulls the point lower to
the third quadrant.
4/ Asynchrony between volume shift and flow: The
nonlinearity in the relationship between volume shift
and flow lies in the asynchrony between this two
factors. It corresponds to airflow drops despite
increasing volume shifts (Fig. 2, panel I.D, it can be
also depicted from Fig. 2, panel II.C). Asynchrony is
a measure expressed as time difference of volume
shift peak and peak of the flow.
5/ SG0.5: Similar to sGAW, yet limited to the linear drop
between right-handside inspiratory and expiratory
flow rates of ±0.5 L/s (Fig. 2, panel I.E.) [6].
Transfer function modelling
Development of the data-based input–output transfer
function models was performed in an offline framework in
MATLAB (8.3, The MathWorks, Natick, Massachusetts)
using the System Identification Toolbox [24]. From the
Masterlab system, measurements of tidal expiration were
exported at a sampling rate of 100Hz. Shape differences of
specific resistance loop were described via relationship of
their two creating factors: flow and volume shift. Volume
shift was used as a model input, while the result of that
generated pressure, flow, was used as a model output (in-
put–output relationship shown in Fig. 2, panel II).
To characterize the breathing process and explain the
data in a parametrically efficient way and yet sustain
simplicity in the sense of model parameters and model
order, an iterative system identification procedure was
used [25]. Based on this procedure we have chosen a
second order discrete-time transfer function (TF) model
(Eq. 2) as most the appropriate.
Table 1 Study population characteristics
Healthy Asthma COPD
Subjects, n 22 22 90
Gender, M/F 16/6 13/9 67/23
Age, years 60 (59–63) 34 (22–49) 65 (58–71)
BMI, kg/m2 24.8 (22.9–27.1) 23.9 (22.3–26.9) 23.6 (21.0–27.8)
FEV1, %predicted 114 (105–124) 107 (93–123) 47 (30–72)
FEV1/FVC, % 74.5 (71.8–77.5) 77 (73–82) 46.5 (32–58)
DL,CO, %predicted 94 (81–100) 88 (81–99) 51 (39–67)
RV, %predicted 101 (93–113) 104 (92–112) 147 (121–190)
TLC, %predicted 112 (106–118) 106 (96–113) 109 (99–127)
FRC, %predicted 120 (102–128) 112 (103–120) 142 (122–184)
RV/TLC, % 34.4 (32.2–36.8) 27.4 (24.0–32.9) 56.3 (41.6–62.7)
RAW, %predicted 86 (76–107) 94 (77–109) 239 (122–333)
sGAW, %predicted 155 (131–192) 128 (108–171) 47 (27–98)
Values are median and IQR
Definition of abbreviations: BMI body mass index, DL,CO carbon monoxide
diffusing capacity, FEV1 forced expiratory volume in one second, FRC functional
residual capacity, RV residual volume, RAW airway resistance, sGAW specific airway
conductance, TLC total lung capacity
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H zð Þ ¼ F zð Þ
Vs zð Þ¼
b0 þ b1z−1 þ b2z−2
1þ a1z−1 þ a2z−2 ð2Þ
where F stands for Flow and Vs for Volume shift. Coeffi-
cients a1, a2 and coefficients b0, b1 and b2 are the TF de-
nominator and numerator, respectively. Z is a discrete
domain operator. From the defined second order model,
we further extracted process descriptive parameters:
1/ the steady state gain (SSG), defined as a ratio of the
steady state output and the input (Eq. 3), which in
simplified sense represents volume shift
Fig. 2 Panel I Geometrical parameters in COPD subject: a Area of the loop, b Roundness, c Median point, d Asynchrony, e sG0.5. Panel II
Examples of input–output relationship presented over time: a Healthy subject, b Asthma subject, c COPD subject; Solid line represents flow
(model output), dashed line is volume shift (model input). Transfer function model explains how input transforms to output. Panel III
Visualisation of model performance with modelled expiration (red line) over the original loop (blue line): a Healthy subject (NMRSE = 95%),
b Post methacholine asthma subject (NMRSE = 92%), c COPD subject (NMRSE = 94%)
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multiplication to reach a certain flow level in steady
state conditions.
SSG ¼ ΔF zð Þ
ΔVs zð Þ ¼
X2
i¼0bi
1þ
X2
i¼1ai
ð3Þ
2/ using denominator coefficients, two dynamic components
of tidal expiration were derived: namely Pole1 and Pole2
(i.e. the roots of the denominator) (Eq. 4).
Pole1;2 ¼ a1 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
a12−4a2
p
2
ð4Þ
3/ finally, the numerator coefficients (b0, b1, and b2),
were used for group comparison.
Statistical analysis
JMP Pro version 12, (SAS Institute, Cary, USA) was used
to perform statistical analysis. The Shapiro-Wilk test
was used to inspect normality of the groups. To control
differences between two groups (paired or unpaired,
where appropriate) with parametric and non-parametric
distribution T-test and Mann–Whitney test were used,
respectively. In the case of multiple group comparisons,
ANOVA or Kruskal-Wallis tests were performed, de-
pending of group distribution. The logistic-regression
model was applied for binary variables analyses, where
in addition stepwise selection was used to identify the
subset of variables that had the strongest relation to out-
come, using default criteria of significance at the 0.25
level to enter and 0.5 level to leave the model. The
model consisted of lung function parameters: FVC, %pred,
FEV1, %pred, FEV1/FVC, %pred, PEF, %pred. TLC, %pred,
RV, %pred, FRC, %pred., DL,CO, %pred, KCO, %pred., RV/
TLC. To determine normal value range, two-sided predic-
tion interval of 99% was applied.
Results
Models
The assessment of the geometrical parameters was pos-
sible with the data of all subjects. Due to instable results
of TF model parameters (|z| > 1), one healthy and ten
COPD subjects were excluded from further analysis [26].
In general, confirmation of the appropriate model selection
was demonstrated with a high goodness of fit expressed as
normalized root mean square error (NRMSE) of 90
(85–92)% (values are median and IQR) for complete
dataset. A visualisation of the model performance with
its accuracy is shown in Fig. 2, Panel III.
Table 2 depicts the median values of all resistive pa-
rameters in each group, revealing significant differences
in the majority of parameters when comparing COPD
with Asthma or Healthy controls, and no significant differ-
ences between non-obstructive asthmatics and healthy
controls. As expected, all geometrical parameters reflect-
ing the opening of the loop (Roundness, Area of loop and
Asynchrony) are significantly different in COPD. Point X
and b’s from TF confirm that with airways obstruction in
COPD, an increased pressure (increased volume shift) has
to be generated to maintain tidal breathing without sig-
nificant changes in flow (Point Y). This is coherent with
the measuring standard of whole-body plethysmography
where the subjects are instructed for a tidal breathing at
1 Hz at FRC securing similar flows for everyone (disease
independent).
Table 2 Resistive parameters in different groups
Healthy Asthma COPD p value
(H vs. A)
p value
(H vs. C)
p value
(A vs. C)
Roundness 0.04 (0.03–0.07) 0.07 (0.04–0.09) 0.41 (0.17–0.58) 0.7900 <0.0001 <0.0001
Area of Loop 0.07 (0.05–0.10) 0.12 (0.08–0.16) 0.38 (0.21–0.51) 0.9189 <0.0001 <0.0001
Asynchrony, msec 10 (0–20) 15 (0–33) 70 (30–140) 0.9064 <0.0001 <0.0001
Point X, ml −29 (−67–−15) −26 (−79–−6) −128 (−318–−48) 0.9999 0.0006 0.0005
Point Y, ml/sec −243 (−470–−25) −195 (−440–37) −331 (−443–−209) 0.9653 0.5014 0.5014
b0 5.66 (3.78–7.43) 5.77 (4.64–7.09) 1.51 (0.84–3.27) 0.9999 <0.0001 <0.0001
b1 −8.88 (−11.8–−5.0) −8.57 (−11.5–−5.6) −2.36 (−4.43–−0.17) 0.8356 <0.0001 <0.0001
b2 4.22 (2.39–5.21) 3.19 (1.10–4.97) 0.90 (−0.18–1.82) 0.9999 <0.0001 <0.0001
SSG, 1/sec 5.48 (4.62–6.21) 5.18 (4.11–6.16) 1.34 (0.62–2.61) 0.9999 <0.0001 <0.0001
Pole1 0.94 (0.90–0.97) 0.95 (0.89–0.97) 0.91 (0.82–0.96) 0.9999 0.4899 0.4068
Pole2 0.93 (0.80–0.96) 0.92 (0.59–0.95) 0.78 (0.53–0.91) 0.6674 0.0241 0.7444
sGAW, 1/ kPa*sec 1.32 (1.12–1.63) 1.09 (0.92–1.45) 0.40 (0.23–0.83) 0.9635 <0.0001 <0.0001
sG0.5 , 1/ kPa*sec 1.42 (1.15–1.57) 1.33 (1.24–1.47) 0.75 (0.49–1.14) 0.9999 <0.0001 <0.0001
Values are median and IQR
Definition of abbreviations: Point X Median point based on median volume shift values, Point Y Median point based on median flow values
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Resistance loop in COPD
As shown in Table 2, most resistance loops of COPD
opened to an imperfect circular shape with significant
differences on roundness, normalized AOL and asyn-
chrony. As multivariate analysis indicated that roundness
from all resistive parameters was the best differentiator
between non-obstructive subjects (asthma and healthy)
and COPD, roundness was chosen as the key variable
to describe opening of the loop (data not shown). When
applying a 99% confidence interval to define the normal
range of roundness in healthy and non-obstructive asthma
subjects, a 0.18 cut-off came out as the upper limit of nor-
mality. When using this > 0.18 cut-off for the definition of
loop opening in COPD, 67/90 patients were considered as
“Openers” whereas 23 were defined as “Non-openers”.
When comparing common lung function parameters be-
tween the group of “Openers” and “Non-openers” in
COPD, it was found that 22 of 23 “Non-openers” were
present in the mild to moderate stages (I and II) of COPD
and that those subjects were characterized by a signifi-
cantly higher FEV1, a lower RV and RV/TLC ratio com-
pared to the “openers” of GOLD stage I and II (Table 3).
Multiple logistic regression with the stepwise selection
demonstrated that in COPD GOLD I and II, RV/TLC
ratio was the only predictor for loop opening with an OR
of 1.157 (95% CI of (1.064–1.267), p value of 0.0006 and
model R2 = 0.35). When looking at all COPD stages, again
RV/TLC associated best with loop opening with an OR of
1.168 (95% CI of (1.092–1.259), p value <0.0001 and
model R2 = 0.61) and a small contribution of FEV1/FVC
ratio (OR (CL) 0.866 (0.746–0.949), p value 0.0004, adding
to total R2 = 0.72). Data presented in Table 4.
Changes in resistance loops during bronchoconstriction
In a subgroup of non-obstructive asthma patients (N = 11),
airway narrowing was induced by increasing levels of
methacholine during a challenge test. In all patients
FEV1 dropped below 20% of its initial value at metha-
choline concentrations <4 mg/ml, indicative for acute
bronchoconstriction with subsequent rises in airways
resistance. These changes were confirmed by a significant
decrease of specific conductance (sGAW and sG0.5), a sig-
nificant increase in median volume shift (point X) and b0
and significant drop in b1 and SSG (data shown in Table 5).
Although the median roundness statistically increased in
the post-methacholine challenge conditions (from 0.08 to
0.13), these small changes were considered not to be rele-
vant as in 7/11 patients roundness stayed under the upper
limit of “Non-openers”. Additionally, normalized AOL
and asynchrony did not change, indicating that differences
in the slope and changes in input related variables (point
X, b0, b1, SSG) were perfectly in phase with changes in
output (flow).
Finally, when comparing resistive and lung function
parameters of obstructed asthma (post methacholine) with
mild to moderate COPD “Openers” and “Non-openers”, it
was clear that obstructive asthma patients presented with
the lowest slopes and highest point X for only little in-
creases of roundness, asynchrony and AOL. By contrast,
COPD openers presented with the highest roundness, asyn-
chrony and AOL. Consistent with previous findings, not
FEV1 (p = 0.093) but RV/TLC ratio (p < 0.0001) was the
main clinical lung function determinant that differentiated
Table 3 Comparison of patients with opened vs. unopened
loop in mild to moderate COPD
Non-openers Openers p value
Subjects, n 22 17
BMI, kg/m2 24.9 (22.0–29.4) 26.8 (24.1–27.8) 0.6093
FEV1, %predicted 83 (76–93) 65 (61–76) 0.0018
DLCO, %predicted 67 (55–79) 69 (53–75) 0.6774
RV, %predicted 115 (106–133) 134 (120–150) 0.0368
TLC, %predicted 109 (99–115) 107 (102–110) 0.6793
FRC, %predicted 122 (101–135) 131 (120–142) 0.1578
RV/TLC, % 38.7 (35.7–40.4) 46.6 (41.5–53.9) 0.0007
sGAW, 1/ kPa*sec 1.03 (0.90–1.21) 0.61 (0.46–0.74) <0.0001
sG0.5 , 1/ kPa*sec 1.23 (1.06–1.38) 1.00 (0.81–1.15) 0.0047
Roundness 0.09 (0.06–0.12) 0.31 (0.22–0.41) <0.0001
Area of Loop 0.14 (0.10–0.20) 0.31 (0.23–0.44) <0.0001
Asynchrony, msec 10 (0–40) 40 (30–70) 0.0097
Point X, ml −38 (−93–−19) −92 (−209–−31) 0.0827
Point Y, ml/sec −251 (−379–−177) −251 (−406–−139) 0.7107
b0 4.10 (2.92–5.56) 1.63 (1.18–2.58) 0.0013
b1 −3.47 (−8.11–1.16) −2.40 (−3.95–0.20) 0.3080
b2 1.42 (−2.87–3.27) 0.77 (−0.46–1.97) 0.5132
SSG, 1/sec 4.03 (2.76–4.54) 1.67 (1.50–2.21) <0.0001
Pole1 0.84 (0.67–0.96) 0.93 (0.82–0.97) 0.2301
Pole2 0.64 (0.26–0.89) 0.86 (0.49–0.95) 0.1216
Values are median and IQR; Differences between groups controlled with T-test
or Mann–Whitney test depending of distribution
Table 4 Relationship between pulmonary function parameters
and the opening of resistance loops in multiple logistic
regression with stepwise selection: A/ in mild to moderate
COPD, B/ in all COPD
Variables Odds Ratio (95% Confidence limit) p value
Mild COPD
RV/TLC, % 1.157 (1.064–1.267) 0.0006
COPD
RV/TLC, % 1.168 (1.092–1.259) <0.0001
FEV1/FVC, % 0.866 (0.746–0.949) 0.0004
In table are shown only significant variables, not excluded by a stepwise
selection. The model consisted of lung function parameters: FVC, %pred,
FEV1, %pred, FEV1/FVC, %pred, PEF, %pred. TLC, %pred, RV, %pred, FRC,
%pred., DL,CO, %pred, KCO, %pred., RV/TLC
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between obstructive asthma and COPD openers (see
Table 6).
Discussion
In this study we describe specific resistance loops mea-
sured by body-plethysmography by using geometrical
analyses and second-order transfer functions. The newly
developed parameters reflect the curvilinear aspect and
rotation of the resistance loops and typically associate
with different lung function characteristics. Loops that
are mathematically identified by an open appearance as
measured by roundness typically occur in the majority
of COPD subjects with hyperinflation, whereas rotation
of the slope without opening is apparent during bronch-
oconstriction, as demonstrated in asthma.
Opening of the loops in COPD was significantly asso-
ciated with RV/TLC ratio, much more than with FEV1
or FEV1/FVC ratio. In numerous studies the RV/TLC ra-
tio has been linked to air trapping and hyperinflation, to-
gether with increases of RV and FRC [27–29]. In fact,
the RV/TLC ratio reflects the proportion of trapped lung
volume that cannot be mobilized by maximal breathing.
Increases in static RV/TLC ratio are inversely correlated
with maximal inspiratory capacity, which often declines
during exercise by dynamic hyperinflation and strongly
associates with breathing discomfort and dyspnea. From
a mechanistic point of view, we can only speculate on
the reasons why RV/TLC ratio is the best predictor for
loop opening and asynchrony between alveolar pressures
and flows. One possible explanation may be found in the
competition for space between lung areas that are emp-
tied during expiration with areas that are trapped with
air and progressively compress adjacent airways during
expiration. As such the heterogeneity of airflow may
contribute to a wide distribution of time constants for
gas emptying and thus asynchrony, typically occurring
with hyperinflation. Heterogeneity in the ventilation may
also occur following bronchoconstriction, but with lim-
ited hyperinflation. As methacholine challenge in the
asthma group did not induce important asynchrony, one
may hypothesize that a more homogenous reduction in
flow was obtained. A last explanation may be found in
increased airway collapse by reduced airway tethering
Table 5 Lung function and resistance parameters in the subgroup
of asthma patients with pre and post methacholine challenge test
Pre Post p value
Subjects, n 11 11
Openers, n 0 4
FEV1, %predicted 108 (91–115) 75 (67–89) <0.0001
RV, %predicted 107 (102–118) 132 (115–162) 0.0188
TLC, %predicted 106 (95–113) 102 (89–115) 0.2014
FRC, %predicted 116 (110–120) 130 (123–140) 0.0508
RV/TLC, % 27.4 (26.4–32.5) 32.1 (27.9–48.4) 0.1289
sGAW, 1/ kPa*sec 1.02 (0.88–1.10) 0.45 (0.38–0.51) 0.0010
sG0.5 , 1/ kPa*sec 1.28 (1.24–1.34) 0.63 (0.57–0.69) 0.0010
Roundness 0.08 (0.02–0.09) 0.13 (0.12–0.27) 0.0029
Area of Loop 0.14 (0.02–0.18) 0.14 (0.13–0.19) 0.1678
Asynchrony, msec 20 (0–20) 20 (20–50) 0.1339
Point X, ml −14 (−27–1) −115 (−172–3) 0.0137
Point Y, ml/sec −158 (−188–73) −258 (−399–−42) 0.2447
b0 6.04 (4.68–7.03) 2.03 (1.67–4.11) 0.0049
b1 −7.72 (−11.14–−5.20) −2.37 (−4.45–0.06) 0.0105
b2 2.92 (0.87–4.15) 0.91 (−0.88–2.09) 0.1242
SSG, 1/sec 5.00 (4.16–5.89) 2.13 (1.41–2.90) 0.0020
Pole1 0.95 (0.86–0.97) 0.90 (0.57–0.94) 0.3203
Pole2 0.85 (0.16–0.95) 0.71 (0.45–0.91) 0.8984
Values are median and IQR; Differences between groups controlled with T-test
or Mann–Whitney test depending of distribution
Table 6 Comparison of groups where flow limitation is undoubted
Post methacholine Asthma (A) Non-Openers mild COPD (B) Openers mild COPD (C) p value
(A vs. B)
p value
(A vs. C)
Subjects, n 11 22 17
FEV1, %predicted 75 (67–89) 83 (76–93) 65 (61–76) 0.3757 0.0937
FEV1/FVC, % 65 (60–69) 62 (58–68) 55 (48–61) 0.7242 0.0027
RV/TLC, % 32.1 (27.9–48.4) 38.7 (35.7–40.4) 46.6 (41.5–53.9) <0.0001 <0.0001
sGAW, 1/ kPa*sec 0.45 (0.38–0.51) 1.03 (0.90–1.21) 0.61 (0.46–0.74) <0.0001 0.2420
sG0.5 , 1/ kPa*sec 0.63 (0.57–0.69) 1.23 (1.06–1.38) 1.00 (0.81–1.15) <0.0001 0.0033
Roundness 0.13 (0.12–0.27) 0.09 (0.06–0.12) 0.31 (0.22–0.41) 0.0309 0.0656
Area of Loop 0.14 (0.13–0.19) 0.14 (0.10–0.20) 0.31 (0.23–0.44) 0.6732 <0.0001
SSG, 1/sec 2.13 (1.41–2.90) 4.03 (2.76–4.54) 1.67 (1.50–2.21) 0.0022 0.2651
Point X, ml −115 (−172–3) −38 (−93–−19) −92 (−29–−31) - -
Asynchrony, msec 20 (20–50) 10 (0–43) 40 (30–65) 0.9999 0.4266
Values are median and IQR; Differences between groups controlled with ANOVA or Kruskal-Wallis test, depending of distribution. In case significant difference is
observed, post-hoc analysis is performed and p values are reported
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with the loss of alveolar tissue. We did not observe any
significant relationship between roundness and DLCO or
KCO, as indicative lung function markers of emphysema.
Unfortunately, in the absence of CT measures we were
not able to study the relationship with emphysema in
more depth. From a clinical point of view the strong as-
sociation between the roundness of resistance loops and
hyperinflation is very attractive. The reduction of static
hyperinflation is a main target of several COPD treatments
including lung volume reduction surgery, endoscopic
valve displacement and bronchodilators. Bronchodilator
responses are usually evaluated on the expiratory vol-
umes of spirometry, although different studies suggest
that their impact on static lung volumes may be much
larger [30–32]. Therefore, the monitoring of hyperinflation
during tidal breathing may become a promising evaluation
tool for treatment responses in specific phenotypes.
Our data clearly indicate that bronchoconstriction due
to airway muscle contraction and mucosal oedema in
asthma is resulting in significant changes in input related
parameters such as SSG, point X, b0 and b1. These
changes correspond to an increased volume shift in
phase with the flow, which obviously result in a reduction
of the slope. Although most of our asthma patients did
not show opening, 4 subjects had significant increases in
roundness after the bronchial challenge, which is not sur-
prising as hyperinflation can occur during bronchocon-
striction and heterogeneity in airflow during exhalation
may occur with increased bronchoconstriction [33]. When
using sGAW as best correlate for the slope, we accept that
volume shift and airflow have a linear relationship, which
is often not the case. SSG, which is highly correlated to
sGAW, accounts for pressure multiplication to reach the
level of exhaled flow but under steady state condition.
Both SSG and sGAW ignore much of the system’s dynam-
ics, but as they are computed differently they may still be
influenced by other factors in the flow volume shift rela-
tionship. Looking at the slope per se, our data suggest to
use sG0.5 instead of or with sGAW (computed as sGmid)
due to its potential to discriminate obstructive asthma
from mild COPD. As sG0.5 practically represents the slope
of the right hand side of the loop, it will be little influenced
by resistive mechanisms that open the loop.
Previous studies with FOT have demonstrated that
resistance measures can vary within and between breath
as they are flow- and volume dependent. In particular,
bronchomotor challenge can alter the ventilation which
translates into changes of airway resistance and obscures
the true changes in airway patency. Moreover, it has been
shown that in patients with COPD the degree of flow limi-
tation is varying between breaths [12, 34]. In the transition
period of mild disease the detection of flow limitation may
therefore require the monitoring of several breathing
loops. For FOT different mathematical models have been
proposed that correct for loop and flow dependency dur-
ing tidal breathing [12, 15]. Our approach with plethys-
mography is adjusting flows for pressure changes during
the whole breathing cycle and is taking the non-linearity
of these dynamics into account. Indirectly, it also provides
correction for between-breath differences as a representa-
tive breathing cycle of overlapping loops was carefully se-
lected. Taken together, our data imply that airways are not
just simple tubes, but flexible structures that may enlarge
or compress in function of the manoeuver.
The new parameters that we have developed are po-
tentially important as they are able to identify different
phenotypes within the spectrum of obstructive airways
diseases. Hence, it is only with interventions and longi-
tudinal follow-up that we will be able to identify their
exact clinical relevance. One weakness of the study is
the smaller number of healthy subjects, since a larger
number would secure confidence in defining the nor-
mality range for each parameter. Similarly, comparisons
of postbronchodilator with prebronchodilator measures,
particularly in asthma may reveal more subtle differences
between asthma and healthy controls. Another weakness
may be the lack of data from CT scans, as that would
allow the correlation of newly developed parameters with
CT parameters of hyperinflation, airtrapping, bronchial in-
flammation and emphysema [35–37].
Conclusion
We developed new parameters which are reflecting the
dynamic relationships between alveolar pressures and
flows. Some of them are potentially important as they
are linked to specific phenotypes within the spectrum of
obstructive airways diseases. Mechanistic and prospect-
ive follow-up studies are now needed to determine the
true validity of these parameters in respiratory medicine.
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